WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...
Here’s a trio for you: Taylor Swift’s record-shattering The Life Of A Showgirl; Bad Bunny’s culture-defining residency in Puerto Rico (and subsequent, idiot-bothering confirmation for the Super Bowl ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...
Another hair tool for "the perfect blowout?" We'll see about that ...
Oct 30 (Reuters) - Shares of Indian generic drugmaker Dr Reddy's Laboratories (REDY.NS), opens new tab declined more than 5% on Thursday, after the firm received a non-compliance notice for its ...
Dr. Reddy’s Laboratories remains a compelling buy due to underappreciated growth in biosimilars and GLP-1 segments, despite near-term headwinds. RDY's Q2 FY26 results showed modest revenue growth, ...
Anil Sharma’s Lila Global has recruited dry bulk veteran Navin Arjun Soni as chief commercial officer. Soni, who until recently headed Heidmar’s Singapore office, where he spent nearly three years ...
Dr. Navin Arora is a board-certified dermatologist and the founder of Borealis Dermatology, which has locations in Garden City, Syosset and Bellerose. A lifelong New Yorker, Arora has more than 15 ...
HYDERABAD July 23 (Reuters) - Dr Reddy's Laboratories (REDY.NS), opens new tab plans to launch a cheaper copycat version of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster weight-loss drug Wegovy ...
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy — next year, joining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback